KFBIO successfully participated in the United States and Canadian Academy of Pathology (USCAP 2026), presenting the comprehensive digital pathology solutions to global pathology professionals and industry partners. The portfolio at the event featured digital pathology scanner automated stainer and coverslipper slide scanner pathology pathology lab automation solutions as part of the company’s commitment to innovation.

At this year’s exhibition, KFBIO highlighted the integrated product portfolio covering pre-analytical processing, staining and coverslipping, digital slide scanning, and workflow digitization, demonstrating its strong capabilities in building end-to-end pathology solutions, including digital pathology scanner automated stainer and coverslipper slide scanner pathology pathology lab automation technology for laboratories.

Comprehensive Workflow Coverage

KFBIO showcased a range of core products, including:

• Stainer & Coverslipper RF-I
  Ensures standardized staining processes and consistent slide quality, improving laboratory efficiency
• Digital Slide Scanners PRX-M
  Deliver high-throughput and high-resolution scanning to accelerate digital transformation in pathology
• Slide Printer UV-300
  Provides precise and reliable slide identification for optimized laboratory workflow management

By seamlessly integrating these systems, KFBIO enables a streamlined workflow from sample preparation to digital diagnosis. In particular, the digital pathology scanner automated stainer and coverslipper slide scanner pathology pathology lab automation suite enhances operational efficiency.

Strengthening Global Presence in Digital Pathology

As one of the most influential events in the pathology field, USCAP provides a key platform for industry exchange and innovation. Furthermore, adopting digital pathology scanner automated stainer and coverslipper slide scanner pathology pathology lab automation not only drives lab efficiency but also sets new standards for the industry.

Through active engagement with global experts and partners, KFBIO continues to deepen its understanding of international market needs and clinical applications.

KFBIO remains committed to advancing digital pathology worldwide, driving innovation in clinical diagnostics, research, and education.